Cargando…
Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer
The goals of this study were to identify transcriptomic changes that arise in basal-like breast cancer cells during the development of resistance to epidermal growth factor receptor inhibitors (EGFRi) and to identify drugs that are cytotoxic once EGFRi resistance occurs. Human patient-derived xenogr...
Autores principales: | Rashid, Narmeen S., Boyd, David C., Olex, Amy L., Grible, Jacqueline M., Duong, Alex K., Alzubi, Mohammad A., Altman, Julia E., Leftwich, Tess J., Valentine, Aaron D., Hairr, Nicole S., Zboril, Emily K., Smith, Timothy M., Pfefferle, Adam D., Dozmorov, Mikhail G., Harrell, J. Chuck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731984/ https://www.ncbi.nlm.nih.gov/pubmed/36482068 http://dx.doi.org/10.1038/s41598-022-25541-3 |
Ejemplares similares
-
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
por: Boyd, David C., et al.
Publicado: (2023) -
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
por: Rashid, Narmeen S., et al.
Publicado: (2021) -
Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023) -
Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
por: Dozmorov, Mikhail G., et al.
Publicado: (2023) -
Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
por: Dozmorov, Mikhail G., et al.
Publicado: (2023)